Can Celiac Disease Kill You? The Risks Explained

Explore the mortality risks associated with untreated Celiac Disease, including serious complications, and the management strategies that eliminate danger.

Celiac disease does increase the risk of dying, though for most people who are diagnosed and treated, the added risk is modest. A large Swedish study tracking tens of thousands of people with celiac disease found their overall death rate was about 21 percent higher than that of matched controls, translating to roughly one extra death per thousand people per year. That number sits far from a death sentence, but it also means celiac disease is not the harmless dietary inconvenience it is sometimes dismissed as. The ways it can become dangerous range from rare but dramatic emergencies to slow-building complications that unfold over decades, and how well you manage the disease changes the picture substantially.

How Much Does Celiac Disease Raise Mortality Risk?

The clearest picture of celiac disease and death comes from population-level data out of Scandinavia, where national health registries allow researchers to follow large groups over long periods. A 2020 study of nearly 50,000 people with biopsy-confirmed celiac disease found an overall hazard ratio for death of 1.21, meaning about a 21 percent increase compared to people without the condition. In concrete terms, the celiac group experienced roughly 9.7 deaths per 1,000 person-years versus 8.6 in controls, an absolute difference of about 1.2 extra deaths per 1,000 person-years. An earlier Swedish cohort study found a roughly twofold increase in mortality among all hospitalized celiac patients, though the risk dropped to about 1.4-fold when limited to people whose only hospital diagnosis was celiac disease.

Interestingly, not all long-term studies agree on the size of the risk. A Finnish study following celiac patients for a median of over 26 years found that all-cause mortality was not increased overall, though deaths from lymphoproliferative diseases and central nervous system diseases were significantly elevated. The discrepancy likely reflects differences in how well patients adhered to a gluten-free diet, when they were diagnosed, and how severe their disease was at baseline. A separate Swedish biopsy study found that even people with intestinal inflammation that hadn’t yet progressed to full villous atrophy had a 72 percent higher mortality rate, and that excess risk was also seen in children.

The takeaway from these studies is that celiac disease as a whole modestly raises your odds of dying earlier, but the increase is driven disproportionately by people whose disease is poorly controlled, undiagnosed, or complicated by other conditions. For someone diagnosed early and committed to a strict gluten-free diet, the excess risk shrinks considerably.

Celiac Crisis, the Acute Emergency

The most immediately life-threatening scenario in celiac disease is something called celiac crisis. It is rare, but when it happens, it requires emergency hospital care. A celiac crisis involves an abrupt onset of severe diarrhea combined with dangerous metabolic disturbances: potassium, sodium, magnesium, and calcium levels plummet, the body becomes profoundly dehydrated, and kidney function can deteriorate rapidly. Neurological dysfunction can also occur. Without treatment, the cascade of organ failures could be fatal.

A case series of adult patients who experienced celiac crisis found that all of them needed hospitalization with intravenous fluids, the majority required corticosteroids, and some needed parenteral nutrition (feeding through a vein). The encouraging detail: all of these patients eventually recovered fully once placed on a strict gluten-free diet. Celiac crisis tends to occur in people who have gone a long time without diagnosis or who have abandoned their gluten-free diet. It is not the kind of thing that blindsides someone who is already managing their disease well.

Refractory Celiac Disease and the Path to Lymphoma

The most ominous complications of celiac disease arise when the gut refuses to heal despite a strict gluten-free diet. This condition, called refractory celiac disease, is uncommon but serious. Most people who seem to not respond to a gluten-free diet are actually still eating gluten inadvertently. True refractory celiac disease, confirmed by biopsy after careful dietitian evaluation and gluten detection testing, is divided into two types.

Type I refractory celiac disease generally carries a good prognosis. One study found a five-year survival rate of 96 percent. Type II is a different story. It is characterized by a population of abnormal immune cells in the gut lining that amount to a low-grade lymphoma, and it frequently progresses to enteropathy-associated T-cell lymphoma, an aggressive cancer. In the same study, 52 percent of type II refractory patients developed that lymphoma within four to six years, and five-year survival after developing it was only 8 percent. Over half of the type II patients died, most of them from the lymphoma itself. More recent cohort data confirms this grim trajectory: in a decade-long study, six of the type II refractory patients developed lymphoma and four died from it.

Type II refractory celiac disease is the single most dangerous consequence of celiac disease, but it is also genuinely rare. Most celiac patients will never develop it. The distinction between the two types requires specialized biopsy analysis, and the subtyping matters enormously because the prognosis and treatment approach are so different.

Cancer Risks Beyond Lymphoma

Enteropathy-associated T-cell lymphoma gets the most attention, but celiac disease also raises the risk of small bowel adenocarcinoma, a cancer of the small intestine lining. A nationwide Swedish cohort study that followed over 48,000 celiac patients found that about three times as many of them developed small bowel adenocarcinoma compared to the general population. That translates to a hazard ratio of roughly 3.05. Small bowel adenomas, which are precancerous growths, were also roughly five to six times more common. Small bowel carcinoids, by contrast, showed no increased risk.

These relative numbers sound alarming, but it helps to remember that small bowel cancers are very uncommon in the general population. A threefold increase of a tiny baseline risk still produces a small absolute risk. In the Swedish cohort, only 29 out of more than 48,000 celiac patients developed small bowel adenocarcinoma over a median follow-up of 11 years, a rate of 0.06 percent. The Finnish long-term study did find that deaths from lymphoproliferative diseases were about 2.4 times more common in the celiac group, confirming that blood and lymph system cancers are a real, though uncommon, contributor to excess mortality.

Cardiovascular Disease

Heart disease is not the first thing people associate with celiac disease, but a large prospective analysis from the UK Biobank found that people with celiac disease had about a 27 percent higher rate of cardiovascular disease compared to those without it. The absolute incidence was about 9 per 1,000 person-years in the celiac group versus roughly 7.4 in controls. The pattern held for ischemic heart disease and heart attacks specifically, and the association actually strengthened after adjusting for conventional cardiovascular risk factors like blood pressure and cholesterol.

The mechanism is not entirely settled. Chronic systemic inflammation is the leading candidate: celiac disease drives ongoing immune activation that may promote damage to blood vessel walls. Malabsorption of nutrients involved in cardiovascular health, like folate and B vitamins, might also play a role. What this means practically is that people with celiac disease may want to be especially attentive to the standard cardiovascular risk factors they can control, since they may be starting from a slightly higher baseline of risk.

Splenic Dysfunction and Vulnerability to Infections

An underappreciated danger of celiac disease is its effect on the spleen. More than a third of adult celiac patients have some degree of defective splenic function, a condition called hyposplenism. The spleen is a key organ for clearing certain types of bacteria from the blood, particularly encapsulated bacteria like the pneumococcus. When it underperforms, the body becomes less able to fight off these infections, and sepsis from pneumococcal disease can progress rapidly and be fatal.

Some clinical guidelines recommend that celiac patients, especially those with confirmed hyposplenism or complicated disease, receive pneumococcal vaccination. A systematic review examined the association between celiac disease and pneumococcal infection and found the link plausible through the hyposplenism pathway, though large-scale confirmation of the magnitude of increased risk is still limited. The risk of blood clots is also elevated in people with hyposplenism, adding another dimension to how the spleen’s decline can contribute to serious harm.

Neurological Harm

Celiac disease can damage the nervous system, sometimes severely. Neurological manifestations include gluten ataxia (loss of coordination), peripheral neuropathy (numbness and tingling in the hands and feet), epilepsy, and cognitive decline including dementia. These complications can develop even when gut symptoms are minimal, which makes them easy to miss.

In extreme cases, celiac-related neurological disease has been fatal. A case report from the medical literature describes a 57-year-old man with celiac disease who developed progressive degeneration of the brain and spinal cord despite intensive medical and nutritional care. The pattern of damage, predominantly affecting the cerebellum and certain brainstem structures, appeared to represent a distinct entity of central nervous system degeneration associated with celiac disease whose exact cause remains unknown. Cases like this are rare, but they underscore that celiac disease is not purely a gastrointestinal condition. The Finnish long-term study mentioned earlier found central nervous system disease was one of the specific causes of death elevated in celiac patients.

Mental Health and Suicide Risk

Living with celiac disease takes a psychological toll that carries its own mortality risk. A Swedish nationwide cohort study found that people with celiac disease had a 55 percent higher risk of dying by suicide compared to the general population. The finding was based on 54 completed suicides and was statistically robust. Celiac disease is also associated with higher rates of depression, anxiety, and other mood disorders.

It is not clear how much of this reflects the biological effects of the disease on the brain (through inflammation or nutrient deficiencies) versus the psychosocial burden of living with a chronic, socially isolating dietary restriction. Probably both contribute. Either way, the elevated suicide risk makes mental health screening a legitimate concern for celiac patients and their doctors, not an afterthought.

Pregnancy Complications From Undiagnosed Celiac Disease

Women with celiac disease face elevated rates of several serious pregnancy complications. A systematic review and meta-analysis of 18 studies found significantly higher risks of spontaneous abortion, fetal growth restriction, stillbirth, and preterm delivery. Stillbirth risk was roughly 57 percent higher, and fetal growth restriction was about 68 percent more likely. A separate study reported that over half of women with celiac disease experienced spontaneous abortion, compared to about 40 percent of controls.

The critical detail from the meta-analysis is that subgroup analysis showed these elevated risks were driven almost entirely by undiagnosed celiac disease. Women who were diagnosed early and presumably managing the disease with a gluten-free diet did not show a significant increase in adverse pregnancy outcomes. This is one of the clearest examples in the celiac literature of how diagnosis timing changes the stakes. For a woman with unexplained recurrent miscarriages or unexplained growth restriction in pregnancy, undiagnosed celiac disease is worth testing for.

When Celiac Disease Coexists With Type 1 Diabetes

Celiac disease and type 1 diabetes overlap more often than chance would predict, because both are autoimmune conditions that share genetic risk factors. When the two coexist, the mortality picture worsens over time. A study of people with both conditions found that celiac disease was not an additional risk factor for death during the first five years after celiac diagnosis, but the risk climbed steadily thereafter. After 15 or more years of living with both conditions, the risk of death was nearly three times higher than for people with type 1 diabetes alone.

The mechanism likely involves the compounding effects of chronic inflammation and nutrient malabsorption on top of the vascular damage that diabetes itself causes. For people managing both conditions, the stakes of strict gluten-free diet adherence are higher, and the timeline over which complications accumulate is longer.

Malnutrition in Children

In children, the most immediate danger from celiac disease is malnutrition. A cross-sectional study of children with celiac disease found that roughly a quarter had low body weight and a similar proportion had short stature, depending on which growth standard was used. The most common clinical features included abdominal pain in over half the children, followed by skeletal pain, constipation, and anemia. One case report documented a pediatric patient with celiac disease who developed pancytopenia (dangerously low blood cell counts), severe protein loss through the gut, and vitamin B12 deficiency, all of which resolved on a gluten-free diet with supportive care.

Severe malnutrition in children is not just a growth problem. When protein levels drop far enough and the body can no longer make adequate blood cells, the risk of overwhelming infection and organ failure rises steeply. In parts of the world where celiac disease goes unrecognized or where gluten-free food is hard to access, children remain especially vulnerable.

The Barrier of Food Insecurity

A strict gluten-free diet is the only established treatment for celiac disease, but maintaining one is harder than it sounds, and not just because of willpower or knowledge. Gluten-free food costs more, is less available in many communities, and can be difficult to find in rural areas or food deserts. Research over the past five years has shown that food insecurity negatively affects quality of life, worsens symptoms, and lowers adherence to the gluten-free diet, especially in children and low-income families.

A pediatric study quantified this more precisely: children in households that were gluten-free food insecure took significantly longer to achieve normalized antibody levels, which is the key marker of mucosal healing. Food insecurity was also tied to worse overall diet adherence and more frequent gluten consumption due to transportation barriers, cost, and limited availability of safe food. Since all the serious long-term complications of celiac disease, from lymphoma to cardiovascular disease to bone loss, are amplified by ongoing gut damage from gluten exposure, the inability to afford or access gluten-free food is itself a risk factor for the most dangerous outcomes. The lethality of celiac disease is not evenly distributed; it tracks with the same socioeconomic inequalities that shape health outcomes everywhere.